Calendar Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Market Closed - OTC Markets 20:42:01 09/05/2024 BST 5-day change 1st Jan Change
0.1959 USD +3.11% Intraday chart for Provectus Biopharmaceuticals, Inc. +2.40% +104.06%

Chart calendar Provectus Biopharmaceuticals, Inc.

aeaabec9bc7.CnM0-cl6MkLOU6jIb9PVL_-rBtjPI6juQD8dIfUAxbI.R0Fxiv4qY3ecOP2ePuKTZq7IV--BUsOlOndodLJYtstrImGdjwJDM_40ww~6b144f972ed94eda5d846a1472a4c151

Upcoming events on Provectus Biopharmaceuticals, Inc.

14/05/2024 Society for Investigative Dermatology Meeting

Past events on Provectus Biopharmaceuticals, Inc.

04/04/2024 American Association for Cancer Research Meeting
22/02/2024 20:00 Business Update Call
05/11/2023 Society for Melanoma Research Congress - Combination PV-10 autolytic immunotherapy
05/11/2023 Society for Melanoma Research Congress - Percutaneous autolytic immunotherapy
31/10/2023 Society for Immunotherapy of Cancer Meeting
30/11/2022 Melanoma Bridge Conference
22/06/2022 21:00 Annual Genral Meeting
16/06/2022 International Society of Ocular Oncology Congress
06/06/2022 19:15 American Society of Clinical Oncology Meeting - Abstract No 9543
07/04/2022 American Association of Cancer Research Meeting - Abstract No 2720
09/03/2022 European Neuroendocrine Tumor Society Conference - Abstract No: 3455, I25
27/10/2021 Society for Melanoma Research Meeting - Cutaneous Melanoma
27/10/2021 Society for Melanoma Research Congress - Checkpoint Blockade
15/09/2021 ESMO Congress Conference - Abstract No - 4354
23/06/2021 21:00 Annual Genral Meeting
08/11/2020 Society of Immunotherapy of Cancer Meeting - Abstract Number : 585
18/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4397
18/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4281
21/06/2020 American Association for Cancer Research Virtual Meeting - Abstract number: 5393
28/05/2020 American Society of Clinical Oncology Virtual Annual Meeting - Abstract No - 1
  1. Stock Market
  2. Equities
  3. PVCT Stock
  4. Calendar Provectus Biopharmaceuticals, Inc.